Drug intelligence / Profile preview

Changluo Tiaogan Dingsoul

Development stage: Preclinical
Lead developer: Science and Technology Bureau of Xianyang City
Administration: Oral

Overview

Changluo Tiaogan Dingsoul is a traditional Chinese medicine decoction being investigated for the treatment of coronary heart disease complicated with anxiety disorder. Its therapeutic approach is based on the traditional Chinese medicine concept of "Chang Luo Tiao Shen".

Other names: Changluo Tiaogan Dingsoul decoction

Beyond the preview

Go deeper on Changluo Tiaogan Dingsoul.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Changluo Tiaogan Dingsoul.